Büchele Gustavo Luiz, Silva Eliézer, Ospina-Tascón Gustavo Adolfo, Vincent Jean-Louis, De Backer Daniel
Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Belgium.
Crit Care Med. 2009 Apr;37(4):1341-7. doi: 10.1097/ccm.0b013e3181986647.
To evaluate the effects of hydrocortisone on microcirculatory blood flow alterations in patients with septic shock.
Prospective, open-label study.
A 31-bed, medico-surgical intensive care unit of a university hospital.
Twenty patients with septic shock.
Intravenous hydrocortisone (50 mg/6 hr).
An orthogonal polarization spectral device (Cytoscan ARII, Cytometrics; Philadelphia, PA) was used to investigate the sublingual microcirculation in 20 patients who received so-called "stress doses" of hydrocortisone as part of their management for septic shock. Hemodynamic measurements and orthogonal polarization spectral images were obtained before administration of the first dose (50 mg) of hydrocortisone and 1, 2, 4, and 24 hours later. Measurements were also made before an adrenocorticotropic hormone (ACTH) test, whenever performed. Global hemodynamic variables were similar at all study time points. Microcirculatory variables improved slightly already at 1 hour after the start of hydrocortisone administration. In particular, perfused vessel density increased from 5.7 (4.8-6.4) to 7.2 (6.5-9.0)n/mm, p < 0.01, which was due to combined increases in small vessel density from 5.2 (4.6-6.2) to 6.0 (5.1-7.5)n/mm, p < 0.01, and in the proportion of perfused vessels from 82.1 (68.7-88.0) to 89.2 (83.4-92.6)%, p < 0.01. There were no differences in microcirculatory variables during hydrocortisone administration between ACTH test responders and nonresponders.
The administration of moderate doses of hydrocortisone in septic shock results in a modest but consistent improvement in capillary perfusion, independent of the response to the ACTH test. The mechanisms underlying this effect need to be elucidated.
评估氢化可的松对感染性休克患者微循环血流改变的影响。
前瞻性、开放标签研究。
一所大学医院的拥有31张床位的内科-外科重症监护病房。
20例感染性休克患者。
静脉注射氢化可的松(50毫克/6小时)。
使用正交极化光谱装置(Cytoscan ARII,Cytometrics公司;宾夕法尼亚州费城)对20例接受所谓“应激剂量”氢化可的松治疗的感染性休克患者进行舌下微循环研究。在首次给予氢化可的松剂量(50毫克)前以及给药后1、2、4和24小时获取血流动力学测量值和正交极化光谱图像。在进行促肾上腺皮质激素(ACTH)试验前(若进行该试验)也进行测量。所有研究时间点的整体血流动力学变量相似。氢化可的松给药开始后1小时,微循环变量即有轻微改善。特别是,灌注血管密度从5.7(4.8 - 6.4)增加至7.2(6.5 - 9.0)n/mm,p < 0.01,这是由于小血管密度从5.2(4.6 - 6.2)增加至6.0(5.1 - 7.5)n/mm,p < 0.01,以及灌注血管比例从82.1(68.7 - 88.0)%增加至89.2(83.4 - 92.6)%,p < 0.01共同导致的。ACTH试验反应者与无反应者在氢化可的松给药期间的微循环变量无差异。
感染性休克患者给予中等剂量氢化可的松可使毛细血管灌注有适度但持续的改善,且与对ACTH试验的反应无关。这种效应的潜在机制有待阐明。